tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AVTX Stock Latest News

Avalo Therapeutics Appoints Michael Heffernan as Chairman
Company AnnouncementsAvalo Therapeutics Appoints Michael Heffernan as Chairman
15d ago
8K
AVTX
Avalo Therapeutics appoints Heffernan as Chairman of the Board
PremiumThe Fly
Avalo Therapeutics appoints Heffernan as Chairman of the Board
15d ago
AVTX
Avalo Therapeutics initiated with a Buy at Stifel
PremiumThe Fly
Avalo Therapeutics initiated with a Buy at Stifel
15d ago
ABBV
AVTX
Avalo Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Avalo Therapeutics initiated with a Buy at Jefferies
15d ago
AVTX
Promising Outlook for Avalo Therapeutics’ AVTX-009 in HS Treatment
PremiumRatings
Promising Outlook for Avalo Therapeutics’ AVTX-009 in HS Treatment
16d ago
AVTX
Promising Investment Opportunity in Avalo Therapeutics: Strong Financial Position and Breakthrough HS Treatment
PremiumRatingsPromising Investment Opportunity in Avalo Therapeutics: Strong Financial Position and Breakthrough HS Treatment
20d ago
AVTX
Avalo Therapeutics reports FY24 EPS ($20.91) vs ($113.58) last year
Premium
The Fly
Avalo Therapeutics reports FY24 EPS ($20.91) vs ($113.58) last year
21d ago
AVTX
Walgreens downgraded, Cava Group upgraded: Wall Street’s top analyst calls
Premium
The Fly
Walgreens downgraded, Cava Group upgraded: Wall Street’s top analyst calls
1M ago
LI
DIN
Piper Sandler bullish on Avalo Therapeutics, initiates with an Overweight
PremiumThe Fly
Piper Sandler bullish on Avalo Therapeutics, initiates with an Overweight
1M ago
AVTX
MLTX
Avalo Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Avalo Therapeutics initiated with an Overweight at Piper Sandler
1M ago
AVTX
Rivian downgraded, Unity upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Rivian downgraded, Unity upgraded: Wall Street’s top analyst calls
2M ago
U
CLS
Avalo Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Avalo Therapeutics initiated with an Outperform at Wedbush
2M ago
AVTX
Avalo Therapeutics initiated with an Outperform at Wedbush
PremiumThe FlyAvalo Therapeutics initiated with an Outperform at Wedbush
2M ago
AVTX
Avalo Therapeutics Appoints New Chief Strategy Officer
Premium
Company Announcements
Avalo Therapeutics Appoints New Chief Strategy Officer
3M ago
8K
AVTX
Avalo Therapeutics appoints Jennifer Riley as Chief Strategy Officer
Premium
The Fly
Avalo Therapeutics appoints Jennifer Riley as Chief Strategy Officer
3M ago
AVTX
Avalo Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
Avalo Therapeutics initiated with a Buy at BTIG
4M ago
AVTX
Avalo Therapeutics initiated with a Buy at Lucid Capital
PremiumThe Fly
Avalo Therapeutics initiated with a Buy at Lucid Capital
4M ago
AVTX
Avalo Therapeutics (AVTX) Is a Potential Hidden Gem with Significant Risk
PremiumMarket News
Avalo Therapeutics (AVTX) Is a Potential Hidden Gem with Significant Risk
4M ago
AVTX
Avalo Therapeutics receives $69.4M in proceeds from exercise of warrants
PremiumThe Fly
Avalo Therapeutics receives $69.4M in proceeds from exercise of warrants
5M ago
AVTX
Avalo Therapeutics reports Q3 EPS ($2.83) vs ($22.83) last year
PremiumThe FlyAvalo Therapeutics reports Q3 EPS ($2.83) vs ($22.83) last year
5M ago
AVTX
Avalo Therapeutics, Inc. (AVTX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Avalo Therapeutics, Inc. (AVTX) Q3 Earnings Cheat Sheet
5M ago
AVTX
Avalo Therapeutics initiated with a Neutral at H.C. Wainwright
Premium
The Fly
Avalo Therapeutics initiated with a Neutral at H.C. Wainwright
6M ago
AVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >